CR GROUP L.P. sold 48.7% of their position (7.75M shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $2.41M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/22/2023ACC: 0001209191-23-050375
-7.75M
Net shares
Net seller
$2.41M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
7.75M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−3.10M
Price / share
$0.31
Trade value
$963.12K
% of position
20.4%
9/20/2023
15.17M→12.07M
Common Stock
Indirect
Shares
−1.93M
Price / share
$0.31
Trade value
$599.74K
% of position
20.4%
9/20/2023
9.45M→7.52M
Common Stock
Indirect
Shares
−620.17K
Price / share
$0.31
Trade value
$192.62K
% of position
20.4%
9/20/2023
3.03M→2.41M
Common Stock
Indirect
Shares
−2.10M
Price / share
$0.31
Trade value
$652.81K
% of position
20.4%
9/20/2023
10.29M→8.18M
Total
Net shares
−7.75M
Net value
-$2.41M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/20/2023 | S · Sale | −3.10M | $0.31 | $963.12K | 20.4% | 15.17M | 12.07M |
| Common Stock Indirect | 9/20/2023 | S · Sale | −1.93M | $0.31 | $599.74K | 20.4% | 9.45M | 7.52M |
| Common Stock Indirect | 9/20/2023 | S · Sale | −620.17K | $0.31 | $192.62K | 20.4% | 3.03M | 2.41M |
| Common Stock Indirect | 9/20/2023 | S · Sale | −2.10M | $0.31 | $652.81K | 20.4% | 10.29M | 8.18M |
| Total | −7.75M | -$2.41M | ||||||
Derivative Transactions0
No derivative transactions reported